ArticleJournal of thoracic disease2018

Sortilin as a new membrane inhibitor of EGFR trafficking for overcoming resistance to EGFR inhibitors in non-small cell lung cancer.

Qianping Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.